Literature DB >> 17949993

A new Gateway vector and expression protocol for fast and efficient recombinant protein expression in Mycobacterium smegmatis.

Rachael M Goldstone1, Nicole J Moreland, Ghader Bashiri, Edward N Baker, J Shaun Lott.   

Abstract

A major obstacle associated with recombinant protein over-expression in Escherichia coli is the production of insoluble inclusion bodies, a problem particularly pronounced with Mycobacterium tuberculosis proteins. One strategy to overcome the formation of inclusion bodies is to use an expression host that is more closely related to the organism from which the proteins are derived. Here we describe methods for efficiently identifying M. tuberculosis proteins that express in soluble form in Mycobacterium smegmatis. We have adapted the M. smegmatis expression vector pYUB1049 to the Gateway cloning system by the addition of att recombination recognition sequences. The resulting vector, designated pDESTsmg, is compatible with our in-house Gateway methods for E. coli expression. A target can be subcloned into pDESTsmg by a simple LR reaction using an entry clone generated for E. coli expression, removing the need to design new primers and re-clone target DNA. Proteins are expressed by culturing the M. smegmatis strain mc(2)4517 in autoinduction media supplemented with Tween 80. The media used are the same as those used for expression of proteins in E. coli, simplifying and reducing the cost of the switch to an alternative host. The methods have been applied to a set of M. tuberculosis proteins that form inclusion bodies when expressed in E. coli. We found that five of eight of these previously insoluble proteins become soluble when expressed in M. smegmatis, demonstrating that this is an efficient salvage strategy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17949993     DOI: 10.1016/j.pep.2007.08.015

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  27 in total

1.  Cloning, expression, purification, crystallization and preliminary X-ray studies of the C-terminal domain of Rv3262 (FbiB) from Mycobacterium tuberculosis.

Authors:  Aisyah M Rehan; Ghader Bashiri; Neil G Paterson; Edward N Baker; Christopher J Squire
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-09-30

2.  Elongation of the Poly-γ-glutamate Tail of F420 Requires Both Domains of the F420:γ-Glutamyl Ligase (FbiB) of Mycobacterium tuberculosis.

Authors:  Ghader Bashiri; Aisyah M Rehan; Sreevalsan Sreebhavan; Heather M Baker; Edward N Baker; Christopher J Squire
Journal:  J Biol Chem       Date:  2016-02-09       Impact factor: 5.157

3.  Molecular Cloning, Purification and Characterization of Mce1R of Mycobacterium tuberculosis.

Authors:  Dipanwita Maity; Rajasekhara Reddy Katreddy; Amitava Bandhu
Journal:  Mol Biotechnol       Date:  2021-01-09       Impact factor: 2.695

4.  HisB from Mycobacterium tuberculosis: cloning, overexpression in Mycobacterium smegmatis, purification, crystallization and preliminary X-ray crystallographic analysis.

Authors:  Mohammad Syed Ahangar; Yogesh Khandokar; Nazia Nasir; Rajan Vyas; Bichitra K Biswal
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-10-27

5.  Recombinant expression of a functional myo-inositol-1-phosphate synthase (MIPS) in Mycobacterium smegmatis.

Authors:  Xinyi Huang; Marcy Hernick
Journal:  Protein J       Date:  2015-10       Impact factor: 2.371

6.  Purification and characterization of the acyltransferase involved in biosynthesis of the major mycobacterial cell envelope glycolipid--monoacylated phosphatidylinositol dimannoside.

Authors:  Zuzana Svetlíková; Peter Baráth; Mary Jackson; Jana Korduláková; Katarína Mikušová
Journal:  Protein Expr Purif       Date:  2014-05-06       Impact factor: 1.650

7.  Serological evaluation of Mycobacterium ulcerans antigens identified by comparative genomics.

Authors:  Sacha J Pidot; Jessica L Porter; Laurent Marsollier; Annick Chauty; Florence Migot-Nabias; Cyril Badaut; Angèle Bénard; Marie-Therese Ruf; Torsten Seemann; Paul D R Johnson; John K Davies; Grant A Jenkin; Gerd Pluschke; Timothy P Stinear
Journal:  PLoS Negl Trop Dis       Date:  2010-11-02

8.  Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from Korea and analysis of the correlation between the mutations and pyrazinamidase activity.

Authors:  Jee-Hyun Yoon; Ji-Sun Nam; Kyung-Jin Kim; Young-Tae Ro
Journal:  World J Microbiol Biotechnol       Date:  2014-07-18       Impact factor: 3.312

9.  Immunotherapeutic efficacy of recombinant Mycobacterium smegmatis expressing Ag85B-ESAT6 fusion protein against persistent tuberculosis infection in mice.

Authors:  Ping Wang; Limei Wang; Wei Zhang; Yinlan Bai; Jian Kang; Yanfei Hao; Tailai Luo; Changhong Shi; Zhikai Xu
Journal:  Hum Vaccin Immunother       Date:  2013-08-27       Impact factor: 3.452

10.  Overexpression, purification, crystallization and structure determination of AspB, a putative aspartate aminotransferase from Mycobacterium tuberculosis.

Authors:  Deepak Chandra Saroj; Khundrakpam Herojit Singh; Avishek Anant; Bichitra K Biswal
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-06-18       Impact factor: 1.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.